19-6007712-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000635.4(RFX2):c.1225G>A(p.Gly409Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,554,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000635.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFX2 | NM_000635.4 | c.1225G>A | p.Gly409Ser | missense_variant | 11/18 | ENST00000303657.10 | NP_000626.2 | |
RANBP3-DT | NR_046376.1 | n.113-4408C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFX2 | ENST00000303657.10 | c.1225G>A | p.Gly409Ser | missense_variant | 11/18 | 1 | NM_000635.4 | ENSP00000306335 | P3 | |
RANBP3-DT | ENST00000587836.1 | n.113-4408C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152062Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000236 AC: 38AN: 160992Hom.: 0 AF XY: 0.000294 AC XY: 25AN XY: 84984
GnomAD4 exome AF: 0.000120 AC: 168AN: 1402012Hom.: 0 Cov.: 31 AF XY: 0.000110 AC XY: 76AN XY: 691928
GnomAD4 genome AF: 0.000105 AC: 16AN: 152180Hom.: 0 Cov.: 31 AF XY: 0.0000806 AC XY: 6AN XY: 74398
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | The c.1225G>A (p.G409S) alteration is located in exon 11 (coding exon 10) of the RFX2 gene. This alteration results from a G to A substitution at nucleotide position 1225, causing the glycine (G) at amino acid position 409 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at